Wei Xue
About Wei Xue
Wei Xue is a Sr. Manager Biostatistician at Kite Pharma, where he has worked since 2022. He holds a Doctor of Public Health and a Master of Public Health from the University of North Carolina at Chapel Hill, and has extensive experience in biostatistics and data science across various organizations.
Work at Kite Pharma
Wei Xue has been serving as a Senior Manager Biostatistician at Kite Pharma since 2022. In this role, Xue is responsible for leading biostatistical efforts in the development of innovative therapies. Kite Pharma focuses on cell therapy for cancer treatment, and Xue's expertise contributes to the statistical analysis and interpretation of clinical trial data, ensuring the integrity and scientific validity of research outcomes.
Education and Expertise
Wei Xue holds a Doctor of Public Health (DrPH) and a Master of Public Health (MPH) in Biostatistics from the University of North Carolina at Chapel Hill, where Xue studied from 2011 to 2016. Additionally, Xue earned a Master of Science (MS) in Biochemistry and Molecular Biology from Sichuan University. Xue's educational background provides a strong foundation in statistical methodologies and public health principles.
Professional Background
Wei Xue has extensive experience in biostatistics and data analysis. Prior to joining Kite Pharma, Xue worked at Biogen as a Principal Biostatistician from 2020 to 2022. Xue also held various positions at IQVIA, including Data Scientist/Statistician (Manager, Centralized Monitoring) from 2018 to 2020, Sr. IPT Specialist from 2015 to 2018, and Biostatistician Intern from 2014 to 2015. Xue began their career at the University of North Carolina at Chapel Hill, working as a Statistician and SAS Programmer.
Career Achievements
Throughout their career, Wei Xue has contributed to significant projects in biostatistics and public health. Xue's work at the University of North Carolina at Chapel Hill involved statistical analysis in various research initiatives, while roles at Biogen and IQVIA focused on advanced statistical methodologies in clinical research. Xue's expertise in biostatistics has been instrumental in supporting data-driven decisions in healthcare.